Elevated C-reactive protein levels in women with bipolar disorder may be explained by a history of childhood trauma, especially sexual abuse, body mass index and age

CNS and Neurological Disorders - Drug Targets

Volumn 16, Issue 4, 2017, Pages 514-521

  Moraes, Juliana Brum ^a   Maes, Michael ^a,b,c,d   Barbosa, Decio Sabbatini ^a   Ferrari, Thais Zagabria ^a   Uehara, Marcela Keikko Spagolla ^a   Carvalho, André F ^e   Nunes, Sandra Odebrecht Vargas ^a  

^a STATE UNIVERSITY OF LONDRINA   (Brazil)

^b CHULALONGKORN UNIVERSITY   (Thailand)

^c MEDICAL UNIVERSITY OF PLOVDIV   (Bulgaria)

^d DEAKIN UNIVERSITY   (Australia)

^e FEDERAL UNIVERSITY OF CEARÁ   (Brazil)

Author keywords

Bipolar disorder; C reactive protein; Childhood sexual abuse; Depression; Early life stress; Immune activation; Inflammation

Indexed keywords

C REACTIVE PROTEIN; BIOLOGICAL MARKER;

ADULT; AGE; ARTICLE; BIPOLAR DISORDER; BODY MASS; CASE CONTROL STUDY; CHILDHOOD TRAUMA QUESTIONNAIRE; CONTROLLED STUDY; DEPRESSION; DSM-IV; EARLY LIFE STRESS; EMOTIONAL ABUSE; FAMILY HISTORY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; NEPHELOMETRY; PHYSICAL ABUSE; SCORING SYSTEM; SENSITIVITY AND SPECIFICITY; SEXUAL ABUSE; STRUCTURED INTERVIEW; SUICIDE ATTEMPT; TOBACCO DEPENDENCE; YOUNG ADULT; ADOLESCENT; AGED; AGING; BLOOD; CHILDHOOD TRAUMA SURVIVOR; CROSS-SECTIONAL STUDY; MENTAL STRESS; METABOLISM; MULTIVARIATE ANALYSIS; QUESTIONNAIRE; STATISTICAL MODEL;

ADOLESCENT; ADULT; ADULT SURVIVORS OF CHILD ADVERSE EVENTS; AGED; AGING; BIOMARKERS; BIPOLAR DISORDER; BODY MASS INDEX; C-REACTIVE PROTEIN; CASE-CONTROL STUDIES; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; LINEAR MODELS; LOGISTIC MODELS; MIDDLE AGED; MULTIVARIATE ANALYSIS; STRESS, PSYCHOLOGICAL; SURVEYS AND QUESTIONNAIRES; YOUNG ADULT;

EID: 85027264257     PISSN: 18715273     EISSN: 19963181     Source Type: Journal    
DOI: 10.2174/1871527316666170407151514     Document Type: Article

References (46)

1. th ed. Washington: American Psychiatric Pushing; 2013.
2. Berk M, Kapczinski F, Andreazza AC, et al. Pathways underlying neuroprogression in bipolar disorder: Focus on inflammation, oxidative stress and neurotrophic factors. Neurosci Biobehav R 2011; 35(3): 804-17.
3. Krishnan, KRR. Psychiatric and medical comorbidities of bipolar disorder. Psychosom Med 2005; 67(1): 1-8.
4. Liu CS, Carvalho AF, Mansur RB, McIntyre RS. Obesity and bipolar disorder: Synergistic neurotoxic effects? Adv Ther 2013; 30(11): 987-1006.
5. Pavlova B, Perlis RH, Alda M, Usher R. Lifetime prevalence of anxiety disorders in people with bipolar disorder: A systematic review and meta-analysis. Lancet Psychiatry 2015; 2(8): 710-7.
6. Simon NM, Otto MW, Wisniewski SR, et al. Anxiety disorder comorbidity in bipolar disorder patients: Data from the first 500 participants in the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD). Am J Psychiatry 2004; 161(12): 2222-9.
7. Post RM. Epigenetic basis of sensitization to stress, affective episodes, and stimulants: Implications for illness progression and prevention. Bipolar Disord 2016; 18(4): 315-25.
8. Etain B, Henry C, Bellivier F, Mathieu F, Leboyer M. Beyond genetics: childhood affective trauma in bipolar disorder. Bipolar Disord 2008; 10(8): 867-76.
9. Modabbernia A, Taslimi S, Brietzke E, Ashrafi M. Cytokine alterations in bipolar disorder: A meta-analysis of 30 studies. Biol Psychiatry 2013; 74(1): 15-25.
10. Dargél AA, Godin O, Kapczinski F, Kupfer DJ, Leboyer M. C-reactive protein alterations in bipolar disorder: A meta-analysis. J Clin Psychiatry 2015; 76(2): 142-50.
11. Anderson G, Maes M. Bipolar disorder: role of immune-inflammatory cytokines, oxidative and nitrosative stress and tryptophan catabolites. Curr Psychiatry Rep 2015; 17(2): 1-9.
12. Maes M, Delange J, Ranjan R, et al. Acute phase proteins in schizophrenia, mania and major depression: Modulation by psychotropic drugs. Psychiatry Res 1997; 66(1): 1-11.
13. Hornig M, Goodman DB, Kamoun M, Amsterdam JD. Positive and negative acute phase proteins in affective subtypes. J Affect Disord 1998; 49(1): 9-18.
14. Maes M. Evidence for an immune response in major depression: A review and hypothesis. Prog Neuropsychopharmacol Biol Psychiatry 1995; 19(1): 11-38.
15. Maes M, Meltzer HY, Bosmans E, et al. Increased plasma concentrations of interleukin-6, soluble interleukin-6, soluble interleukin-2 and transferrin receptor in major depression. J Affect Disord 1995; 34(4): 301-9.
16. Wadee AA, Kuschke RH, Wood LA, Berk M, Ichim L, Maes M. Serological observations in patients suffering from acute manic episodes. Hum Psychopharm Clin 2002; 17(4): 175-9.
17. Magalhães PVS, Fries GR, Kapczinski F. Peripheral markers and the pathophysiology of bipolar disorder. Rev Psiq Clín 2012; 39(2): 60-7.
18. Munkholm K, Vinberg M, Vedel Kessing L. Cytokines in bipolar disorder: A systematic review and meta-analysis. J Affect Disord 2013; 144(1-2): 16-27.
19. Kauer-SantAnna M, Kapczinski F, Andreazza AC, et al. Brain-derived neurotrophic factor and inflammatory markers in patients with early vs. late-stage bipolar disorder. Int. J. Neuropsychopharmacol 2009; 12(4): 447-58.
20. Kapczinski F, Dal-Pizzol F, Teixeira AL, et al. Peripheral biomarkers and illness activity in bipolar disorder. J Psych Res 2011; 45(2): 156-61.
21. Cunha AB, Andreazza AC, Gomes FA, et al. Investigation of serum high-sensitive C-reactive protein levels across all mood states in bipolar disorder. Eur Arch Psychiatry Clin Neurosci 2008; 258(5): 300-04.
22. Marangoni C, Hernandez M, Faedda GL. The role of environmental exposures as risk factors for bipolar disorder: A systematic review of longitudinal studies. J Affect Disord 2016; 193: 165-74.
23. Larsson S, Andreassen OA, Aas M, et al. High prevalence of childhood trauma in patients with schizophrenia spectrum and affective disorder. Compr Psychiatry 2013; 54(2): 123-27.
24. Maniglio, R. Prevalence of child sexual abuse among adults and youths with bipolar disorder: A systematic review. Clin Psychol Rev 2013; 33(4): 561-73.
25. Leboyer M, Etain B, Mathieu F, Henry C, Jamain S,Bellivier F. Childhood affective trauma in bipolar affective disorder. Bipolar Disord 2007; 9 (Suppl 1): 9-10.
26. Garno JL, Goldberg JF, Ramirez PM, Ritzler BA. Impact of childhood abuse on the clinical course of bipolar disorder. Br J Psychiatry 2005; 186, 121-25.
27. Daruy-Filho L, Brietzke E, Lafer B, Grassi-Oliveira R. Childhood maltreatment and clinical outcomes of bipolar disorder. Acta Psychiatr Scand 2011; 124(6): 427-34.
28. Agnew-Blais J, Danese A. Childhood maltreatment and unfavourable clinical outcomes in bipolar disorder: A systematic review and meta-analysis. Lancet Psychiatry 2016; 3(4): 342-9.
29. Danese A, Pariante CM, Caspi A, Taylor A, Poulton R. Childhood maltreatment predicts adult inflammation in a life-course study. Proc Natl Acad Sci U S A 2007; 104(4): 1319-24.
30. Coelho R, Viola TW, Walss-Bass C, Brietzke E, Grassi-Oliveira R. Childhood maltreatment and inflammatory markers: A systematic review. Acta Psychiatr Scand 2014; 129(3): 180-92.
31. Miller GE, Chen E, Fok AK, et al. Low early-life social class leaves a biological residue manifested by decreased glucocorticoid and increased proinflammatory signaling. Proc Natl Acad Sci U S A 2009; 106(34): 14716-21.
32. Carpenter LL, Carvalho JP, Tyrka AR, et al. Decreased adrenocor-ticotropic hormone and cortisol responses to stress in healthy adults reporting significant childhood maltreatment. Biol Psychiatry 2007; 62(10): 1080-87.
33. Carpenter LL, Gawuga CE, Tyrka AR, Lee JK, Anderson GM, Price LH. Association between plasma IL-6 response to acute stress and early-life adversity in healthy adults. Neuropsychopharmacology 2010; 35(13): 2617-23.
34. Danese A, Tan M. Childhood maltreatment and obesity: Systematic review and meta-analysis. Mol Psychiatry 2014; 19(5): 544-54.
35. Del Ben CM, Vilela JAA, Crippa JAS, Hallak JEC, Labate CM, Zuardi AW. Reliability of the structured clinical interview for DSM-IV-clinical version translated into Portuguese. Rev Bras Psiquiatr 2001; 23(3): 156-9.
36. Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry 1960; 23(1): 56.
37. Moreno RA, Moreno DH. Hamilton and Montgomery & Asberg depression rating scales. Rev Psiquiatr Clin 1998; 25(5): 262-72.
38. Grassi-Oliveira R, Stein L, Pezzi J. Translation and content validation of the Childhood Trauma Questionnaire into Portuguese language. Rev Saúde Pública 2006; 40(2): 249-55.
39. Henrique IFS, Micheli D, Lacerda RB, Lacerda LA; Formigoni MLOS. Validation of the Brazilian version of Alcohol, Smoking and Substance Involvement Screening Test (ASSIST). Rev Assoc Med Bras 2004; 50(2): 1-8.
40. Nunes SOV, Watanabe MAE, Morimoto HK, Moriya R, Reiche EMV. The impact of childhood sexual abuse on activation of immunological and neuroendocrine response. Aggress Violent Beh 2010; 15(6): 440-45.
41. Kemp DE, Gao K, Chan PK, Ganocy SJ, Findling RL, Calabrese JR. Medical comorbidity in bipolar disorder: Relationship between illnesses of the endocrine/metabolic system and treatment outcome. Bipolar disord 2010; 12(4): 404-13.
42. Fagiolini A, Frank E, Scott JA, Turkin S, Kupfer DJ. Metabolic Syndrome in bipolar disorder: Findings from the Bipolar Disorder Center for Pennsylvanians. Bipolar Disord 2005; 7(5): 424-30.
43. Vargas HO, Nunes SOV, Barbosa DS, et al. Castelli risk indexes 1 and 2 are higher in major depression but other characteristics of the metabolic syndrome are not specific to mood disorders. Life Sci 2014; 102(1): 65-71.
44. Mansur RB, Brietzke E, McIntyre RS. Is there a "metabolic-mood syndrome"? A review of the relationship between obesity and mood disorders. Neurosci Biobehav Rev. 2015; 52: 89-104.
45. Colpo GD, Leffa DD, Köhler CA, Kapczinski F, Quevedo J, Carvalho AF. Is bipolar disorder associated with accelerating aging? A meta-analysis of telomere length studies. J Affect Disord. 2015; 186: 241-8.
46. Maurya PK, Noto C, Rizzo LB, et al. The role of oxidative and nitrosative stress in accelerated aging and major depressive disorder. Prog Neuropsychopharmacol Biol Psychiatry 2016; 65: 134-44.